South Florida Donor Network confirms the adoption of OrganOx liver perfusion technology, bolstering the company's footprint in the U.S. organ transplant market.
The correction notice confirms South Florida Donor Network's adoption of OrganOx's liver perfusion technology, a positive adoption signal for OrganOx.
South Florida Donor Network has officially integrated OrganOx's advanced liver perfusion technology into its clinical operations. This adoption marks a significant expansion for the medical device firm, signaling increased market penetration for its organ preservation systems in the United States.
The adoption confirms the clinical utility and market acceptance of OrganOx's liver perfusion technology, supporting the company's growth trajectory in the organ transplant sector.